Table 1.
All patients clinicopathological features.
| Items | Total N (%) | TSR<0.5 N (%) | TSR>0.5 N (%) | P value |
|---|---|---|---|---|
| Age (M±SD) | 59.6 ± 8.40 | 59.1 ± 8.30 | 59.9 ± 8.45 | 0.541 |
| Gender | ||||
| Male | 222 (82.2) | 94 (83.2) | 128 (81.5) | 0.725 |
| Female | 48 (18.8) | 19 (16.8) | 29 (18.5) | |
| Tumor location | ||||
| Upper | 31 (11.5) | 16 (14.2) | 15 (9.6) | 0.471 |
| Middle | 134 (49.6) | 53 (46.9) | 81 (51.6) | |
| Low | 105 (38.9) | 44 (38.9) | 61 (38.9) | |
| pT status | ||||
| T1 | 26 (9.6) | 14 (12.4) | 12 (7.6) | 0.507 |
| T2 | 108 (40.0) | 46 (40.7) | 62 (39.5) | |
| T3 | 123 (45.6) | 47 (41.6) | 76 (48.4) | |
| T4 | 13 (4.8) | 6 (5.3) | 7 (4.5) | |
| T1/T2 | 134 (49.6) | 60 (53.1) | 74 (47.1) | 0.334 |
| T3/T4 | 136 (50.4) | 53 (46.9) | 83 (52.8) | |
| pN status | ||||
| N0 | 193 (71.5) | 84 (74.3) | 109 (69.4) | 0.815 |
| N1 | 38 (14.1) | 15 (13.3) | 23 (16.4) | |
| N2 | 24 (8.9) | 9 (8.0) | 15 (5.6) | |
| N3 | 15 (5.6) | 5 (4.4) | 10 (3.7) | |
| Histological grade | ||||
| high | 145 (53.7) | 52 (46.0) | 93 (59.2) | 0.046 |
| middle | 90 (33.3) | 47 (41.6) | 43 (27.4) | |
| low | 35 (13.0) | 14 (12.4) | 21 (13.4) | |
| TNM stage | ||||
| Ⅰ | 62 (23.0) | 27 (23.9) | 35 (22.3) | 0.617 |
| Ⅱ | 140 (51.9) | 61 (54.0) | 79 (50.3) | |
| Ⅲ | 68 (25.2) | 25 (22.1) | 43 (27.4) | |
| Ⅰ/Ⅱ | 202 (74.9) | 88 (77.9) | 114 (72.6) | 0.326 |
| Ⅲ | 68 (25.2) | 25 (22.1) | 43 (27.4) |
Bold indicates values with a significant difference P<0.05